 | • レポートコード：D0GIR-05688 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、神経腫瘍疾患デバイスの世界市場を広く調査・分析し、今後の市場展望をまとめております。神経腫瘍疾患デバイスの種類別市場規模（MRI、CTスキャン、PET、その他）、用途別市場規模（病院、クリニック、診断センター、リファレンス研究所、医学研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Siemens Healthcare、GE Healthcare、Philips Healthcare、Canon Medical Systems、Hitachi Medical ・地域別グローバル市場分析 2015年-2020年 ・神経腫瘍疾患デバイスの北米市場（アメリカ、カナダ、メキシコ） ・神経腫瘍疾患デバイスのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・神経腫瘍疾患デバイスのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・神経腫瘍疾患デバイスの南米市場（ブラジル、アルゼンチン） ・神経腫瘍疾患デバイスの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：MRI、CTスキャン、PET、その他 ・用途別分析：病院、クリニック、診断センター、リファレンス研究所、医学研究所、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Neuro-Oncological Diseases Device market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Neuro-Oncological Diseases Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Neuro-Oncological Diseases Device market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Neuro-Oncological Diseases Device market has been segmented into
MRI
CT Scan
PET
Others
By Application, Neuro-Oncological Diseases Device has been segmented into:
Hospitals
Clinics
Diagnostics Centers
Reference Laboratories
Medical Research Institutes
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Neuro-Oncological Diseases Device market presented in the report. This section sheds light on the sales growth of different regional and country-level Neuro-Oncological Diseases Device markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Neuro-Oncological Diseases Device market.
The report offers in-depth assessment of the growth and other aspects of the Neuro-Oncological Diseases Device market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Neuro-Oncological Diseases Device Market Share Analysis
Neuro-Oncological Diseases Device competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Neuro-Oncological Diseases Device sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Neuro-Oncological Diseases Device sales, revenue and market share for each player covered in this report.
The major players covered in Neuro-Oncological Diseases Device are:
Siemens Healthcare
GE Healthcare
Philips Healthcare
Canon Medical Systems
Hitachi Medical
Among other players domestic and global, Neuro-Oncological Diseases Device market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neuro-Oncological Diseases Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neuro-Oncological Diseases Device, with price, sales, revenue and global market share of Neuro-Oncological Diseases Device in 2018 and 2019.
Chapter 3, the Neuro-Oncological Diseases Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuro-Oncological Diseases Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Neuro-Oncological Diseases Device market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Neuro-Oncological Diseases Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Neuro-Oncological Diseases Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neuro-Oncological Diseases Device Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 MRI
1.2.3 CT Scan
1.2.4 PET
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Neuro-Oncological Diseases Device Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostics Centers
1.3.5 Reference Laboratories
1.3.6 Medical Research Institutes
1.3.7 Others
1.4 Overview of Global Neuro-Oncological Diseases Device Market
1.4.1 Global Neuro-Oncological Diseases Device Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Siemens Healthcare
2.1.1 Siemens Healthcare Details
2.1.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Siemens Healthcare SWOT Analysis
2.1.4 Siemens Healthcare Product and Services
2.1.5 Siemens Healthcare Neuro-Oncological Diseases Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GE Healthcare SWOT Analysis
2.2.4 GE Healthcare Product and Services
2.2.5 GE Healthcare Neuro-Oncological Diseases Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Philips Healthcare
2.3.1 Philips Healthcare Details
2.3.2 Philips Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Philips Healthcare SWOT Analysis
2.3.4 Philips Healthcare Product and Services
2.3.5 Philips Healthcare Neuro-Oncological Diseases Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Canon Medical Systems
2.4.1 Canon Medical Systems Details
2.4.2 Canon Medical Systems Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Canon Medical Systems SWOT Analysis
2.4.4 Canon Medical Systems Product and Services
2.4.5 Canon Medical Systems Neuro-Oncological Diseases Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hitachi Medical
2.5.1 Hitachi Medical Details
2.5.2 Hitachi Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hitachi Medical SWOT Analysis
2.5.4 Hitachi Medical Product and Services
2.5.5 Hitachi Medical Neuro-Oncological Diseases Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Neuro-Oncological Diseases Device Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Neuro-Oncological Diseases Device Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Neuro-Oncological Diseases Device Manufacturer Market Share in 2019
3.3.2 Top 6 Neuro-Oncological Diseases Device Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Neuro-Oncological Diseases Device Sales, Revenue and Market Share by Regions
4.1.1 Global Neuro-Oncological Diseases Device Sales and Market Share by Regions (2015-2020)
4.1.2 Global Neuro-Oncological Diseases Device Revenue and Market Share by Regions (2015-2020)
4.2 North America Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
4.3 Europe Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
4.5 South America Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Neuro-Oncological Diseases Device Sales, Revenue and Market Share by Country
5.1.1 North America Neuro-Oncological Diseases Device Sales and Market Share by Country (2015-2020)
5.1.2 North America Neuro-Oncological Diseases Device Revenue and Market Share by Country (2015-2020)
5.2 United States Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
5.3 Canada Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
5.4 Mexico Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Neuro-Oncological Diseases Device Sales, Revenue and Market Share by Country
6.1.1 Europe Neuro-Oncological Diseases Device Sales and Market Share by Country (2015-2020)
6.1.2 Europe Neuro-Oncological Diseases Device Revenue and Market Share by Country (2015-2020)
6.2 Germany Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
6.3 UK Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
6.4 France Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
6.5 Russia Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
6.6 Italy Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Neuro-Oncological Diseases Device Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Neuro-Oncological Diseases Device Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Neuro-Oncological Diseases Device Revenue and Market Share by Regions (2015-2020)
7.2 China Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
7.3 Japan Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
7.4 Korea Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
7.5 India Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
7.7 Australia Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Neuro-Oncological Diseases Device Sales, Revenue and Market Share by Country
8.1.1 South America Neuro-Oncological Diseases Device Sales and Market Share by Country (2015-2020)
8.1.2 South America Neuro-Oncological Diseases Device Revenue and Market Share by Country (2015-2020)
8.2 Brazil Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
8.3 Argentina Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Neuro-Oncological Diseases Device Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Neuro-Oncological Diseases Device Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Neuro-Oncological Diseases Device Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
9.3 Turkey Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
9.4 Egypt Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
9.5 South Africa Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Neuro-Oncological Diseases Device Sales and Market Share by Type (2015-2020)
10.2 Global Neuro-Oncological Diseases Device Revenue and Market Share by Type (2015-2020)
10.3 Global Neuro-Oncological Diseases Device Price by Type (2015-2020)
11 Global Neuro-Oncological Diseases Device Market Segment by Application
11.1 Global Neuro-Oncological Diseases Device Sales Market Share by Application (2015-2020)
11.2 Global Neuro-Oncological Diseases Device Revenue Market Share by Application (2015-2020)
11.3 Global Neuro-Oncological Diseases Device Price by Application (2015-2020)
12 Market Forecast
12.1 Global Neuro-Oncological Diseases Device Sales, Revenue and Growth Rate (2021-2025)
12.2 Neuro-Oncological Diseases Device Market Forecast by Regions (2021-2025)
12.2.1 North America Neuro-Oncological Diseases Device Market Forecast (2021-2025)
12.2.2 Europe Neuro-Oncological Diseases Device Market Forecast (2021-2025)
12.2.3 Asia-Pacific Neuro-Oncological Diseases Device Market Forecast (2021-2025)
12.2.4 South America Neuro-Oncological Diseases Device Market Forecast (2021-2025)
12.2.5 Middle East & Africa Neuro-Oncological Diseases Device Market Forecast (2021-2025)
12.3 Neuro-Oncological Diseases Device Market Forecast by Type (2021-2025)
12.3.1 Global Neuro-Oncological Diseases Device Sales Forecast by Type (2021-2025)
12.3.2 Global Neuro-Oncological Diseases Device Market Share Forecast by Type (2021-2025)
12.4 Neuro-Oncological Diseases Device Market Forecast by Application (2021-2025)
12.4.1 Global Neuro-Oncological Diseases Device Sales Forecast by Application (2021-2025)
12.4.2 Global Neuro-Oncological Diseases Device Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Neuro-Oncological Diseases Device Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Neuro-Oncological Diseases Device by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Neuro-Oncological Diseases Device Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Siemens Healthcare Basic Information, Manufacturing Base and Competitors
Table 8. Siemens Healthcare Neuro-Oncological Diseases Device Major Business
Table 9. Siemens Healthcare Neuro-Oncological Diseases Device Total Revenue (USD Million) (2018-2019)
Table 10. Siemens Healthcare SWOT Analysis
Table 11. Siemens Healthcare Neuro-Oncological Diseases Device Product and Services
Table 12. Siemens Healthcare Neuro-Oncological Diseases Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 14. GE Healthcare Neuro-Oncological Diseases Device Major Business
Table 15. GE Healthcare Neuro-Oncological Diseases Device Total Revenue (USD Million) (2018-2019)
Table 16. GE Healthcare SWOT Analysis
Table 17. GE Healthcare Neuro-Oncological Diseases Device Product and Services
Table 18. GE Healthcare Neuro-Oncological Diseases Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Philips Healthcare Basic Information, Manufacturing Base and Competitors
Table 20. Philips Healthcare Neuro-Oncological Diseases Device Major Business
Table 21. Philips Healthcare Neuro-Oncological Diseases Device Total Revenue (USD Million) (2018-2019)
Table 22. Philips Healthcare SWOT Analysis
Table 23. Philips Healthcare Neuro-Oncological Diseases Device Product and Services
Table 24. Philips Healthcare Neuro-Oncological Diseases Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Canon Medical Systems Basic Information, Manufacturing Base and Competitors
Table 26. Canon Medical Systems Neuro-Oncological Diseases Device Major Business
Table 27. Canon Medical Systems Neuro-Oncological Diseases Device Total Revenue (USD Million) (2018-2019)
Table 28. Canon Medical Systems SWOT Analysis
Table 29. Canon Medical Systems Neuro-Oncological Diseases Device Product and Services
Table 30. Canon Medical Systems Neuro-Oncological Diseases Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Hitachi Medical Basic Information, Manufacturing Base and Competitors
Table 32. Hitachi Medical Neuro-Oncological Diseases Device Major Business
Table 33. Hitachi Medical Neuro-Oncological Diseases Device Total Revenue (USD Million) (2018-2019)
Table 34. Hitachi Medical SWOT Analysis
Table 35. Hitachi Medical Neuro-Oncological Diseases Device Product and Services
Table 36. Hitachi Medical Neuro-Oncological Diseases Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Neuro-Oncological Diseases Device Sales by Manufacturer (2018-2019) (Units)
Table 38. Global Neuro-Oncological Diseases Device Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Neuro-Oncological Diseases Device Sales by Regions (2015-2020) (Units)
Table 40. Global Neuro-Oncological Diseases Device Sales Market Share by Regions (2015-2020)
Table 41. Global Neuro-Oncological Diseases Device Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Neuro-Oncological Diseases Device Sales by Countries (2015-2020) (Units)
Table 43. North America Neuro-Oncological Diseases Device Sales Market Share by Countries (2015-2020)
Table 44. North America Neuro-Oncological Diseases Device Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Neuro-Oncological Diseases Device Revenue Market Share by Countries (2015-2020)
Table 46. Europe Neuro-Oncological Diseases Device Sales by Countries (2015-2020) (Units)
Table 47. Europe Neuro-Oncological Diseases Device Sales Market Share by Countries (2015-2020)
Table 48. Europe Neuro-Oncological Diseases Device Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Neuro-Oncological Diseases Device Sales by Regions (2015-2020) (Units)
Table 50. Asia-Pacific Neuro-Oncological Diseases Device Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Neuro-Oncological Diseases Device Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Neuro-Oncological Diseases Device Sales by Countries (2015-2020) (Units)
Table 53. South America Neuro-Oncological Diseases Device Sales Market Share by Countries (2015-2020)
Table 54. South America Neuro-Oncological Diseases Device Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Neuro-Oncological Diseases Device Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Neuro-Oncological Diseases Device Sales by Countries (2015-2020) (Units)
Table 57. Middle East & Africa Neuro-Oncological Diseases Device Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Neuro-Oncological Diseases Device Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Neuro-Oncological Diseases Device Revenue Market Share by Countries (2015-2020)
Table 60. Global Neuro-Oncological Diseases Device Sales by Type (2015-2020) (Units)
Table 61. Global Neuro-Oncological Diseases Device Sales Share by Type (2015-2020)
Table 62. Global Neuro-Oncological Diseases Device Revenue by Type (2015-2020) (USD Million)
Table 63. Global Neuro-Oncological Diseases Device Revenue Share by Type (2015-2020)
Table 64. Global Neuro-Oncological Diseases Device Sales by Application (2015-2020) (Units)
Table 65. Global Neuro-Oncological Diseases Device Sales Share by Application (2015-2020)
Table 66. Global Neuro-Oncological Diseases Device Sales Forecast by Regions (2021-2025) (Units)
Table 67. Global Neuro-Oncological Diseases Device Market Share Forecast by Regions (2021-2025)
Table 68. Global Neuro-Oncological Diseases Device Sales Forecast by Type (2021-2025) (Units)
Table 69. Global Neuro-Oncological Diseases Device Market Share Forecast by Type (2021-2025)
Table 70. Global Neuro-Oncological Diseases Device Sales Forecast by Application (2021-2025)
Table 71. Global Neuro-Oncological Diseases Device Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Neuro-Oncological Diseases Device Picture
Figure 2. Global Sales Market Share of Neuro-Oncological Diseases Device by Type in 2019
Figure 3. MRI Picture
Figure 4. CT Scan Picture
Figure 5. PET Picture
Figure 6. Others Picture
Figure 7. Neuro-Oncological Diseases Device Sales Market Share by Application in 2018
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Diagnostics Centers Picture
Figure 11. Reference Laboratories Picture
Figure 12. Medical Research Institutes Picture
Figure 13. Others Picture
Figure 14. Global Neuro-Oncological Diseases Device Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Neuro-Oncological Diseases Device Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Neuro-Oncological Diseases Device Sales Market Share by Manufacturer in 2019
Figure 35. Global Neuro-Oncological Diseases Device Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Neuro-Oncological Diseases Device Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Neuro-Oncological Diseases Device Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 40. Global Neuro-Oncological Diseases Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Neuro-Oncological Diseases Device Revenue Market Share by Regions (2015-2020)
Figure 42. Global Neuro-Oncological Diseases Device Revenue Market Share by Regions in 2018
Figure 43. North America Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
Figure 44. Europe Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
Figure 46. South America Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020)
Figure 48. North America Neuro-Oncological Diseases Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Neuro-Oncological Diseases Device Sales Market Share by Countries (2015-2020)
Figure 50. North America Neuro-Oncological Diseases Device Sales Market Share by Countries in 2018
Figure 51. North America Neuro-Oncological Diseases Device Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Neuro-Oncological Diseases Device Revenue Market Share by Countries in 2018
Figure 53. United States Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 54. Canada Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 55. Mexico Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 56. Europe Neuro-Oncological Diseases Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Neuro-Oncological Diseases Device Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Neuro-Oncological Diseases Device Revenue Market Share by Countries in 2019
Figure 59. Germany Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 60. UK Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 61. France Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 62. Russia Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 63. Italy Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 64. Asia-Pacific Neuro-Oncological Diseases Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Neuro-Oncological Diseases Device Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Neuro-Oncological Diseases Device Revenue Market Share by Regions 2019
Figure 67. China Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 68. Japan Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 69. Korea Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 70. India Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 71. Southeast Asia Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 72. South America Neuro-Oncological Diseases Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Neuro-Oncological Diseases Device Sales Market Share by Countries in 2019
Figure 74. South America Neuro-Oncological Diseases Device Revenue Market Share by Countries in 2019
Figure 75. Brazil Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 76. Argentina Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 77. Middle East and Africa Neuro-Oncological Diseases Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Neuro-Oncological Diseases Device Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Neuro-Oncological Diseases Device Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Neuro-Oncological Diseases Device Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 82. Egypt Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 83. Turkey Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 84. South Africa Neuro-Oncological Diseases Device Sales and Growth Rate (2015-2020) (Units)
Figure 85. Global Neuro-Oncological Diseases Device Sales and Growth Rate (2021-2025) (Units)
Figure 86. Global Neuro-Oncological Diseases Device Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Neuro-Oncological Diseases Device Market Forecast (2021-2025) (Units)
Figure 88. Europe Sales Neuro-Oncological Diseases Device Market Forecast (2021-2025) (Units)
Figure 89. Asia-Pacific Sales Neuro-Oncological Diseases Device Market Forecast (2021-2025) (Units)
Figure 90. South America Sales Neuro-Oncological Diseases Device Market Forecast (2021-2025) (Units)
Figure 91. Middle East & Africa Sales Neuro-Oncological Diseases Device Market Forecast (2021-2025) (Units)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
神経医療デバイスの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Neuro Medical Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…- 自己免疫疾患診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Diagnosis of Autoimmune Diseases market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
- 筋骨格系疾患治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Musculoskeletal Diseases Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Musculoske…
- リソソーム蓄積症治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Lysosomal Storage Diseases Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lysos…
- 後天性希少血液疾患治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Acquired Orphan Blood Diseases Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The A…